PRDS Annual EBITDA
-$99.82 M
-$61.33 M-159.35%
31 December 2022
Summary:
As of February 5, 2025, PRDS annual earnings before interest, taxes, depreciation & amortization is -$99.82 million, with the most recent change of -$61.33 million (-159.35%) on December 31, 2022.PRDS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRDS Quarterly EBITDA
-$12.62 M
+$7.19 M+36.32%
30 June 2023
Summary:
As of February 5, 2025, PRDS quarterly earnings before interest, taxes, depreciation & amortization is -$12.62 million, with the most recent change of +$7.19 million (+36.32%) on June 30, 2023. Over the past year, it has increased by +$15.32 million (+54.84%).PRDS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRDS TTM EBITDA
-$82.88 M
+$15.32 M+15.60%
30 June 2023
Summary:
As of February 5, 2025, PRDS TTM earnings before interest, taxes, depreciation & amortization is -$82.88 million, with the most recent change of +$15.32 million (+15.60%) on June 30, 2023. Over the past year, it has dropped by -$7.70 million (-10.24%).PRDS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRDS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -159.3% | +54.8% | -10.2% |
| 3 y3 years | - | -178.7% | -1731.2% |
| 5 y5 years | - | -178.7% | -1731.2% |
PRDS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +159.3% | +178.7% | +1731.2% |
Pardes Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$12.62 M(-36.3%) | -$82.88 M(-15.6%) |
| Mar 2023 | - | -$19.81 M(-24.3%) | -$98.20 M(-1.6%) |
| Dec 2022 | -$99.82 M | -$26.16 M(+7.7%) | -$99.82 M(+13.5%) |
| Sept 2022 | - | -$24.29 M(-13.0%) | -$87.96 M(+17.0%) |
| June 2022 | - | -$27.93 M(+30.4%) | -$75.18 M(+35.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$21.43 M(+49.8%) | -$55.39 M(+43.9%) |
| Dec 2021 | -$38.49 M | -$14.31 M(+24.2%) | -$38.49 M(+59.2%) |
| Sept 2021 | - | -$11.52 M(+41.5%) | -$24.18 M(+90.9%) |
| June 2021 | - | -$8.14 M(+79.8%) | -$12.67 M(+179.8%) |
| Mar 2021 | - | -$4.53 M | -$4.53 M |
FAQ
- What is Pardes Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Pardes Biosciences?
- What is Pardes Biosciences annual EBITDA year-on-year change?
- What is Pardes Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Pardes Biosciences?
- What is Pardes Biosciences quarterly EBITDA year-on-year change?
- What is Pardes Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Pardes Biosciences?
- What is Pardes Biosciences TTM EBITDA year-on-year change?
What is Pardes Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PRDS is -$99.82 M
What is the all time high annual EBITDA for Pardes Biosciences?
Pardes Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$38.49 M
What is Pardes Biosciences annual EBITDA year-on-year change?
Over the past year, PRDS annual earnings before interest, taxes, depreciation & amortization has changed by -$61.33 M (-159.35%)
What is Pardes Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PRDS is -$12.62 M
What is the all time high quarterly EBITDA for Pardes Biosciences?
Pardes Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$4.53 M
What is Pardes Biosciences quarterly EBITDA year-on-year change?
Over the past year, PRDS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$15.32 M (+54.84%)
What is Pardes Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PRDS is -$82.88 M
What is the all time high TTM EBITDA for Pardes Biosciences?
Pardes Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$4.53 M
What is Pardes Biosciences TTM EBITDA year-on-year change?
Over the past year, PRDS TTM earnings before interest, taxes, depreciation & amortization has changed by -$7.70 M (-10.24%)